Skip to main content
. 2022 May 16;79(20):2001–2017. doi: 10.1016/j.jacc.2022.03.348

Central Illustration.

Central Illustration

Change in Worldwide Cardiovascular Disease Diagnostic Testing Volume From Baseline

(Top) Bar chart of cardiovascular disease test volumes at the 669 participating centers, by International Atomic Energy Agency world regions, for 2019 baseline, the beginning of the pandemic (April 2020), and 1 year into the pandemic (April 2021). Note different y-axes for world regions and worldwide. Percentage reductions from 2019 are reported at the tops of the columns. (Bottom) World map demonstrating changes in total cardiovascular procedural volume from March 2019 to April 2021 across the 107 participating countries. Countries or territories of a country in gray did not have data available. Procedures recorded included morphologic and other types of rest imaging (transthoracic and transesophageal echocardiography, cardiac magnetic resonance [CMR], and positron emission tomography [PET] for infective endocarditis), coronary imaging (coronary computed tomographic angiography, coronary artery calcium scoring, and invasive coronary angiography), and stress testing (stress electrocardiography, stress echocardiography, nuclear stress imaging [single-photon emission computed tomography and PET], and stress CMR). For each numerical range specified by a color, the lower limit provided is inclusive whereas the upper limit is exclusive; for example, –100 to –75 reflects a % change that is ≥–100%, but <–75%, while 75 to 100 reflects a % change that is ≥75%, but <100%.